Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.34 |
| ▸ | NR1D1 | P20393 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 4/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | BCHE | P06276 | 2/20 | 0.33 |
| ▸ | ACHE | P22303 | 2/20 | 0.33 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6486287 | 0.77 | HTR2B (0.39) | MAPTKDM4EMAOBCYP1A2LMNA | |
| SCHEMBL7159370 | 0.71 | PTPRF (0.36) | CA2MAPTMAOBCYP1A2LMNA | |
| SCHEMBL134524 | 0.67 | TSHR (0.60) | CNR2CA2KDM4EAOC3MAPK1 | |
| Bromide SCHEMBL6760453 | 0.65 | CNR2 (0.58) | CNR2CA2KDM4EAOC3MAPK1 | |
| SCHEMBL12049793 | 0.65 | CNR2 (0.64) | CNR2CA2KDM4EAOC3MAPK1 | |
| Bromide SCHEMBL11212819 | 0.65 | CNR2 (0.58) | CNR2CA2KDM4EAOC3MAPK1 | |
| Hydrochloric Acid SCHEMBL2137949 | 0.65 | CNR2 (0.58) | CNR2CA2KDM4EAOC3LMNA | |
| Fluoride SCHEMBL633879 | 0.65 | CNR2 (0.58) | CNR2CA2KDM4EAOC3MAPK1 | |
| Ammonia Solution, Strong SCHEMBL1348044 | 0.65 | CNR2 (0.58) | CNR2CA2KDM4EAOC3MAPK1 | |
| Water SCHEMBL4610445 | 0.65 | CNR2 (0.58) | CNR2CA2KDM4EAOC3MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6964981-B2 | Tetrahydrofuran derivatives and their use as NK-1 antagonists | MERCK SHARP & DOHME LTD. (GB) | 2005-11-15 | — | — | US | disclosed |
| US-20030199500-A1 | Tetrahydrofuran derivatives and their use as nk-1 antagonists | MERCK SHARP & DOHME LTD. (GB) | 2003-10-23 | — | — | US | disclosed |
| EP-1322629-A1 | TETRAHYDROFURAN DERIVATIVES AND THEIR USE AS NK-1 ANTAGONISTS | Merck Sharp & Dohme Limited (GB) | 2003-07-02 | — | — | EP | disclosed |
| WO-2002024673-A1 | TETRAHYDROFURAN DERIVATIVES AND THEIR USE AS NK-1 ANTAGONISTS | MERCK SHARP & DOHME LIMITED (GB) | 2002-03-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030199500-A1 | Tetrahydrofuran derivatives and their use as nk-1 antagonists | GRIK1, OPRK1, GRIK5 | CNR2 117/4885CA2 2714/4885MAPT 4057/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.